ReleVote

Continuing the Suspension of Duty-Free De Minimis Treatment for All Countries

Executive Order Number
14388
President
Donald Trump
Signed
February 20, 2026
Published
February 25, 2026
Source
Federal Register
Original Document
https://www.govinfo.gov/content/pkg/FR-2026-02-25/pdf/2026-03829.pdf

AI-Generated Summary

Summary of Executive Order (Amending Executive Order 14324, February 20, 2026)

Purpose

Continues the suspension of duty-free de minimis treatment under 19 U.S.C. 1321(a)(2)(C) for all imports, including those via the international postal network, to address national emergencies related to illicit drugs across borders, synthetic opioids from China, southern/northern border situations, and U.S. goods trade deficits (as declared in prior EOs 14193, 14194, 14195, 14257). Responds to updated conditions, including invalidated prior duties and readiness of systems for duty collection.

Key Actions and Directives

Significant Changes to Policy or Law

Potential Impacts

Main Stakeholders Affected

Notable Legal, Constitutional, or Political Implications

This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.